https://scholars.lib.ntu.edu.tw/handle/123456789/587988
標題: | Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan | 作者: | LI-KAI TSAI Lin H.-J. Chua S.-K. Liao P.-C. Yang Y.-P. Chou P.-C. Lee C.-W. Lin M.-J. Chen H.-M. Yeh J.-T. Li Y.-H. |
關鍵字: | anticoagulation reversal; bleeding; dabigatran; Idarucizumab; surgery; thrombolysis | 公開日期: | 2018 | 卷: | 27 | 期: | 2 | 起(迄)頁: | e27-e33 | 來源出版物: | Journal of Stroke and Cerebrovascular Diseases | 摘要: | Background: This study aims to observe the effectiveness and safety of idarucizumab in dabigatran-treated patients with severe bleeding or requiring surgery in Taiwan. Methods and Results: In Taiwan, 11 dabigatran-treated patients developed severe bleeding, fracture that needed surgery, and acute ischemic stroke requiring thrombolysis. These patients were treated with idarucizumab and obtained adequate hemostasis. Our experiences reconfirmed the efficacy and safety of idarucizumab in Asian patients. Conclusions: Idarucizumab improves safety in dabigatran-treated patients. Continued education about the availability and appropriate use of idarucizumab is necessary in Asia. ? 2018 National Stroke Association |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033225459&doi=10.1016%2fj.jstrokecerebrovasdis.2017.09.044&partnerID=40&md5=f08c325714589039245007890fd0327a https://scholars.lib.ntu.edu.tw/handle/123456789/587988 |
ISSN: | 10523057 | DOI: | 10.1016/j.jstrokecerebrovasdis.2017.09.044 | SDG/關鍵字: | alteplase; clopidogrel; dabigatran; idarucizumab; rivaroxaban; warfarin; antithrombin; dabigatran; idarucizumab; monoclonal antibody; activated partial thromboplastin time; aged; anticoagulation; Article; atrial fibrillation; bleeding; blood clot lysis; brain hematoma; brain ischemia; clinical article; computer assisted tomography; creatinine clearance; dizziness; drowsiness; drug effect; drug efficacy; drug safety; female; fiberscope endoscopy; fracture; hemianopia; hemiparesis; hemoglobin blood level; hemostasis; human; male; nuclear magnetic resonance imaging; priority journal; rectum hemorrhage; subarachnoid hemorrhage; subdural hematoma; Taiwan; treatment response; very elderly; antagonists and inhibitors; bleeding; blood clotting; case report; chemically induced; evidence based medicine; operative blood loss; risk factor; severity of illness index; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Blood Loss, Surgical; Dabigatran; Evidence-Based Medicine; Female; Hemorrhage; Humans; Male; Risk Factors; Severity of Illness Index; Taiwan |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。